Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX)
Status:
RECRUITING
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
This is an open-label study in adults to determine feasibility of using CYTALUX (pafolacianine) injection with near-infrared (NIR) fluorescent imaging for detecting any type adenocarcinoma (gastric, esophageal and appendiceal).